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The biological role of the ductus arteriosus (DA) in neonates varies from an innocent 
bystander role during normal postnatal transition, to a supportive role when there is 
compromise to either systemic or pulmonary blood flow, to a pathological state in the 
presence of hemodynamically significant systemic to pulmonary shunts, as occurs in 
low birth weight infants. Among a wide array of clinical manifestations arising due to 
the ductal entity, systemic circulatory insufficiency and hypotension are of significant 
concern as they are particularly challenging to manage. An understanding of the phys-
iologic interplay between the DA and the circulatory system is the key to developing 
appropriate targeted therapeutic strategies. In this review, we discuss the relationship 
of systemic hypotension to the DA, emphasizing the importance of critical thinking and 
a precise individual approach to intensive care support. We particularly focus on the 
variable states of hypotension arising directly due to a hemodynamically significant DA 
or seen in the period following successful surgical ligation. In addition, we explore the 
mechanistic contributions of the ductus to circulatory insufficiency that may manifest 
during the transitional period, states of maladapted transition (such as acute pulmonary 
hypertension of the newborn), and congenital heart disease (both ductal dependent and 
non-ductal dependent lesions). Understanding the dynamic modulator role of the ductus 
according to the ambient physiology enables a more precise approach to management. 
We review the pathophysiology, clinical manifestations, diagnosis, monitoring, and ther-
apeutic intervention for the spectrum of DA-related circulatory compromise.
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iNTRODUCTiON
The ductus arteriosus (DA) has a multifaceted biological role in the context of hemodynamic insta-
bility in neonates that ranges from physiologic and supportive to pathologic (Figure 1) (1). Found in 
(almost) every infant at birth, the DA is an anatomical structure that is crucial in maintaining fetal 
circulation and usually undergoes spontaneous closure after aiding a normal circulatory transition. 
A patent DA (PDA) is a DA that remains open past the natural history. The hemodynamically signifi-
cant DA (hsDA) represents the hemodynamic situation where the DA not only remains patent, but 
Abbreviations: CO, cardiac output; DA, ductus arteriosus; DAP, diastolic arterial pressure; LVO, left ventricle output; MAP, 
mean arterial pressure; PDA, patent ductus arteriosus; PVR, pulmonary vascular resistance; PBF, pulmonary blood flow; SBF, 
systemic blood flow; SAP, systolic arterial pressure; SV, stroke volume; SVR, systemic vascular resistance.
FigURe 1 | Relationship between circulatory instability and the ductus arteriosus (DA) in neonates. Acute PH, acute pulmonary hypertension of newborn; CHD, 
congenital heart disease; hsDA, hemodynamic significant DA; PLCS, post-ligation cardiac syndrome.
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where the volume of the transductal shunt is sufficiently large that 
cardiovascular compromise may ensue. In addition, hypotension 
and circulatory insufficiency are also well-known complications 
following treatment to close a DA (2). In this review, we present 
a novel method to assess hemodynamic instability associated 
with the DA and discuss a physiology-based approach to the 
diagnosis and management. The complexity of the physiology of 
these hypotensive states is such that there are clinical situations 
where the patency of the DA can favorably modulate and support 
circulation to vital organs. Differentiation of the supportive from 
the pathological role of the DA is, therefore, essential. Our aim is 
to present the complex mechanistic interplay between hypoten-
sion and the DA that will guide decision-making in critically ill 
neonates.
DA iN FeTAL CiRCULATiON AND eARLY 
TRANSiTiON: ReviSiTiNg THe NORMAL 
PHYSiOLOgY
At birth, infants must navigate a series of complex adaptive 
sequences to successfully transition from fetal to postnatal cir-
culation. The placenta serves as the organ of gas exchange as the 
lungs only receive a small amount of blood flow (3, 4). In the fetal 
circulation, oxygenated blood from the placenta is diverted away 
from the right heart and travels to the left heart via the foramen 
ovale (5). The left heart distributes the oxygenated blood to the 
brain, myocardium, and peripheral circulation, and the right 
heart [which ejects about 65% of the combined ventricular out-
put (6, 7)] receives deoxygenated blood from the fetal veins and 
ejects it into the pulmonary artery (4). Between 40 and 55% of the 
combined cardiac output (CO) diverts through the DA away from 
“the high-resistance pulmonary vascular bed to the low-resistance 
umbilical-placental circulation” (4, 7). Therefore, in the fetal 
circulation, the DA has the crucial biological role of maintaining 
a right-to-left shunt. The elevated pulmonary vascular resistance 
(PVR) that results from fluid-filled fetal alveoli helps drive this 
shunt, while the fetal hypoxic environment promotes produc-
tion of endogenous prostaglandins, primarily prostaglandin E2 
(PGE2) and prostaglandin I2 (PGI2), within the lumen of the DA 
to ensure its ongoing patency. In addition, the intricate balance 
between the maternal uterine and fetal placental prostaglandin 
pathway expression profiles also drives the shunt direction.
After birth, the first breath of relatively oxygenated air results 
in lung expansion and clearance of fetal lung fluid. Mechanical 
stretch of the newly inflated lungs and relief of alveolar hypoxia 
dramatically decrease PVR, leading to an increase in pulmonary 
blood flow (PBF) (8). Clamping of the umbilical cord removes 
the low-resistance placental flow with a subsequent rise in the 
systemic vascular resistance (SVR) and reduction in right heart 
preload. Both cold stress and catecholamine surges will further 
cause the SVR to increase (9). As PVR decreases, the direction of 
flow across the DA changes from all right-to-left (as is seen with 
fetal circulation) to bidirectional. With continued decrease in 
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PVR, the flow pattern becomes predominantly left-to-right and 
directs blood from the aorta to the pulmonary arteries (10). Such 
a change in the shunt direction results in a small, but significant, 
increase in PBF volume that increases pulmonary venous return 
and leads to higher left atrial pressures. This causes displacement 
of the flap of the foramen ovale over the rims of the fossa (5) and 
stops the right-to-left flow through it. Residual left-to-right flow 
through the foramen ovale can commonly be seen for a few days 
as the circulation readjusts.
As the lungs become the organ of gas exchange, the postna-
tal increase in PBF leads to a rapid rise in lung perfusion and 
elevation of neonatal oxygen saturation. During the physiologic 
transition, the increase in systemic arterial oxygen tension 
and decrease in circulating prostaglandin E levels (including 
placental prostaglandins) promotes the constrictive effect 
of oxygen on the ductal tissue (6). This constriction results 
in functional closure of the DA within the first 10–15  h after 
birth. In healthy infants, the functional closure triggers the 
subsequent process of anatomical closure that begins at the 
pulmonary end (11) and is often completed within 2–3 weeks 
of life. In some term infants and many preterm infants, the 
process of physiologic ductal closure can be maladaptive, 
delayed, or even arrested. The DA will close spontaneously in 
most term and preterm infants. In a select number of preterm 
infants, medical therapy will be required to augment closure 
of the DA if it is considered hemodynamically significant; an 
even smaller proportion might benefit from surgical ligation. 
Despite closure (either spontaneously or with medical therapy), 
the DA may reopen with changes in the hemodynamic milieu 
(12), and the persistence of the DA can eventually have serious 
hemodynamic consequences.
ASSeSSMeNT OF DA-ReLATeD 
HeMODYNAMiC iNSTABiLiTY:  
A NOveL APPROACH
The clinical significance of systemic hypotension must be care-
fully interpreted based on the variance in biologic role of the 
DA in different physiologic phases and disease states (5, 10). 
This will enable a clearer understanding of how hemodynamic 
consequences evolve in the context of a DA and ensure proper 
diagnosis, monitoring, and therapeutic intervention when neces-
sary. Although hemodynamic assessment of systemic perfusion 
with echocardiography is more physiologically informative, our 
clinical suspicion of cardiovascular instability should precede 
the use of echocardiography. This crucial “first step” of clinically 
identifying systemic hypotension with low systemic blood flow 
(SBF), however, along the spectrum of DA-related circulatory 
dysfunction, may be difficult based on the inherent limitations 
of its definition. Mean arterial pressure (MAP) is the most com-
mon clinical parameter used to define hemodynamic instability 
and is often used as a surrogate of end-organ perfusion, where 
clinicians rely on the “absolute value” to guide intervention (13). 
The lack of comprehensive normative datasets in neonates (13), 
disconnect between MAP, CO, and target organ flow (10), and 
overreliance on a singular MAP rather than systolic and diastolic 
blood pressures separately (14), limit the use of MAP to monitor 
and treat low blood flow states in preterm and term infants (10).
In clinical terms, neonatologists generally use one of the fol-
lowing three thresholds (5) to define systemic hypotension based 
on blood pressure; first, MAP less than gestational age (GA, in 
weeks) generated by consensus opinion (15) derived from (i) the 
notion that the majority of “healthy” preterm infants have an 
MAP greater than or equal to their GA and (ii) an observation 
from one normative dataset that GA roughly correlated with the 
10th percentile for MAP (16); second, MAP less than 30 mmHg 
based on the assumption that cerebral blood flow becomes pres-
sure dependent at a MAP around 30 mmHg with loss of cerebral 
autoregulation and cerebral white matter damage (17, 18), and a 
population study, which found that the 10th percentile for infants 
of all GA is at or above 30 mmHg at day 3 of life (19); and finally, 
systolic arterial pressure (SAP) and diastolic arterial pressures 
(DAPs) less than the third percentile according to GA based on 
normative data (10, 20, 21).
Since MAP rises as gestational and postnatal age increase 
(22), a single cut-off threshold of MAP-based hypotension (either 
gestational age or number specific) may not be plausible as it var-
ies across gestation in health and disease (5). Furthermore, the 
relative lack of a clear threshold below which autoregulation and 
target organ perfusion are compromised limits the applicability of 
such definitions (5). Owing to the importance of CO (rather than 
MAP) in the regulation of cerebral blood flow (23, 24), and the 
recognition of multiple confounding physiologic differences that 
alter how MAP interacts with SBF, studies compared MAP with 
superior vena cava (SVC) flow, an estimate of CO, and reported 
a weak correlation between these two measures (25–27). One 
study even found that preterm infants with reduced SVC flow 
had normal or high MAP in the first day of life (28). Although 
there is a lack of data demonstrating any benefit to instituting 
treatment to correct MAP above these thresholds (5), using a 
MAP <30 mmHg, when compared to a MAP < GA, as a clini-
cal parameter to predict low CO (low SVC flow) resulted in an 
increase in sensitivity from 30 to 59%, but at the expense of a 
decrease in specificity from 88 to 77% (25).
The individual components of MAP, SAP, and DAP may pro-
vide more valuable insight into the overall wellbeing of the car-
diovascular system as compared to MAP alone and may facilitate 
enhanced diagnostic consideration regarding specific causality 
(5, 10). SAP represents the force of blood exerted on the arterial 
wall in systole and reflects left ventricle (LV) contractile force and 
effective CO; therefore, a low value may indicate reduced stoke 
volume (which is influenced by preload, contractility, and after-
load). DAP represents the resting pressure of blood on the vessels 
and is reflective of systemic vascular tone/resistance and intravas-
cular blood volume status (10). Considering MAP as two separate 
components (SAP and DAP) will reflect a more physiologic basis 
for diagnosis, treatment, and monitoring of low blood flow states 
(5). For example, in the setting of the hsDA, identifying initial 
diastolic hypotension with preserved systolic pressure (wide 
pulse pressure) reflects the initial stages where right ventricle 
(RV) afterload declines and SVR rises after birth in the face of 
mild systemic end organ dysfunction. A progressive decline in 
SAP may reflect a situation where the LV cannot augment systolic 
FigURe 2 | Algorithm for the assessment and treatment of ductus arteriosus (DA)-associated hypotension according to systolic, diastolic, and combined systolic 
and diastolic categories. *Global assessment of systemic perfusion from integration with arterial pressure thresholds may provide early clinical insights regarding 
pathophysiologic determinants of hemodynamic instability, but ascertainment and confirmation of the presence of hemodynamics significance must be obtained 
using comprehensive echocardiography.
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performance to compensate for a rapid increase in preload (high 
volume of PBF returning to left atrium) leading to suboptimal CO 
with both systolic and diastolic hypotension and severe end organ 
dysfunction. This contrasts with states where SAP is low initially 
but in the setting of normal/high DAP; for example, following 
ligation of PDA, acute pulmonary hypertension of the newborn 
(acute PH), and select ductal-dependent congenital heart 
lesions will drive different approaches to optimize CO. Where 
echocardiography assessment of CO is not feasible, surrogate 
measures (e.g., urinary output, arterial pH, and lactate) should 
be used to appraise the impact of arterial pressure thresholds 
on cellular homeostasis. Loss of vascular tone and ventricular 
dysfunction will lead to diastolic hypotension with advanced 
disease. Combined low SAP and DAP may reflect a “common 
end-point” that occurs when the cardiovascular system fails to 
adapt to ongoing hemodynamic stress (10). Comprehension of 
the pathophysiology of hemodynamic instability (whether low 
DAP, low SAP, or both diastolic and systolic hypotension) in 
relation to the DA in these conditions will guide management 
decisions, but its relevance to neonatal outcomes still needs 
prospective evaluation (Figure 2) (5, 10). Arterial pressure does 
not predict CO, and although it may provide insight regarding the 
possibility of an hsDA, ascertainment of the presence of hemo-
dynamics significance can only be obtained using comprehensive 
echocardiography. Global assessment of systemic perfusion and 
integration with arterial pressure thresholds may provide early 
clinical insights regarding pathophysiologic determinants of 
hemodynamic instability, which may be further enhanced by 
comprehensive echocardiography leading to medical precision.
HYPOTeNSiON ReSULTiNg FROM  
AN hsDA
An hsDA in the premature neonate can result in a wide spectrum 
of complex circulatory consequences that manifest with clinical 
signs of pulmonary overcirculation or systemic hypoperfusion 
as the volume of left ventricular output (LVO) is increasingly 
diverted from the systemic to the pulmonary circulation. The 
magnitude of transductal blood flow is modulated by the specific 
sub-components of Poiseulle’s law namely transductal pressure 
gradients, diameter, length, and viscosity. There are multiple 
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mechanistic pathways that lead to the circulatory imbalance with 
an hsDA that can be characterized by the presence of diastolic 
and/or systolic hypotension (5, 10). The risk of refractory hypo-
tension is considerably increased in preterm neonates with an 
hsDA (29), but in order to define systemic hypotension in the 
context of an hsDA, appraisal of the link between MAP and CO 
must account for SVR, according to the relationship, mean blood 
pressure − right atrial pressure = CO × SVR (5). As PVR declines 
after birth, there is a progressive development of a left-to-right 
transductal shunt that can evolve through stages of sufficient to 
inadequate compensatory rise in CO in the setting of an hsDA.
In the initial stage of systemic hypotension related to the hsDA, 
the LV myocardium adapts to increasing left atrial preload (from 
the increased pulmonary venous return) by increasing its stroke 
volume (SV). The hsDA will enlarge the vascular bed and lower net 
SVR, further augmenting the SV with a reduction in LV afterload. 
Clinically, this results in the “paradox” of high ventricular perfor-
mance with increased pre-ductal CO (10, 30–32), characterized 
by low DAP with preserved SAP (wide pulse pressures), but post-
ductal end organ compromise (33). Low coronary perfusion in 
the setting of critical low aortic diastolic pressure may also be 
contributory (34, 35). The inherent functional dysmaturity that 
characterizes the preterm myocardium may further impair these 
compensatory mechanisms.
In general, the premature myocardium is more sensitive to 
changes in afterload with an ineffective contractile mechanism 
and a steeper slope on the stress–velocity curve (10). In addi-
tion, the preterm myocardium is also predisposed to diastolic 
dysfunction owing to the presence of high non-contractile and 
non-compliant collagen fibers (36). Depending on the degree of 
myocardial immaturity, neonates with an hsDA may fail to adapt 
to the sudden increase in preload on the left atrium and properly 
augment its systolic performance (5, 10). With more advanced 
disease, the LV will be unable to maintain the SV according to 
the Frank–Starling relationship, and the inherent decreased 
contractility will lead to further pulmonary congestion, systemic 
hypoperfusion, and severe end organ compromise. This second 
phenotype of low SVR and suboptimal CO (low SV) will lead to 
an overall decline in both SAP and DAP (10). The presence of a 
large left–right transatrial shunt may also limit augmentation of 
CO with similar consequences.
The “ductal steal phenomenon” is another major contributor 
to circulatory imbalance. In the presence of a high systemic to 
pulmonary pressure gradient, an hsDA allows a high volume left-
to-right shunt to “steal” blood away from the systemic circulation 
and into the pulmonary bed. This progressive steal phenomenon 
will lead to systemic circulatory insufficiency that can further 
compromise end organ perfusion, particularly in the postductal 
organs such as kidneys and gastrointestinal tract (30, 31, 37–40). 
Even pre-ductal organs, e.g., heart and brain, are not spared from 
the effects of diastolic runoff as large volume ductal shunts can 
lead to a coronary steal phenomenon (34, 35) and cerebral hypop-
erfusion secondary to impaired perfusion pressure. The imma-
ture cerebral autoregulation in the premature neonate makes this 
at-risk population particularly vulnerable to the effects of low CO 
and ductal steal, thereby increasing the risk of white matter injury 
(41). Additionally, the risk of intraventricular hemorrhage (IVH) 
proportionately increases when the cerebral perfusion is affected 
by an hsDA (42, 43), as infants who developed IVH were noted 
to have a period of sustained augmentation of pre-ductal CO just 
prior to the development of IVH (43).
The presence of diastolic and/or systolic hypotension can 
provide insight into the degree of hemodynamic significance of 
the PDA; however, this approach is yet to be assessed systemati-
cally (5). Diagnosing the exact cause of circulatory instability in 
neonates and ascribing it to an hsDA requires careful synthesis 
of clinical clues, laboratory parameters, and echocardiographic 
findings. Several PDA severity risk scores that evaluate hemody-
namics and clinical significance, predominantly based on echo-
cardiographic parameters, do exist (44–49). These scores provide 
an indirect estimate of shunt volume and the magnitude of 
impact to vital organs, essential for optimization of management. 
Clinical integration of echocardiography parameter with arterial 
pressure thresholds cannot be over emphasized, especially in situ-
ations where septic physiology co-exists with a large hsDA. Newer 
modalities of comprehensive hemodynamic monitoring and 
target organ flow, e.g., near infrared spectroscopy, non-invasive 
CO monitoring, and amplitude integrated electro encephalogram 
may also provide useful additive information (50). A complete 
hemodynamic monitoring protocol that can combine the real-
time information from all these tools is an attractive idea that may 
facilitate early diagnosis and guide treatment, and is currently 
under investigation (51, 52).
The principles of management may also differ based on the 
presence of diastolic and/or systolic hypotension. In the initial 
phase of an hsDA, the first line management of diastolic hypoten-
sion revolves around augmentation of ductal closure with shunt 
limitation strategies that decrease the left-to-right flow gradient 
by increasing PVR [e.g., permissive hypercapnemia, minimiz-
ing FiO2 requirement (53), optimizing positive end expiratory 
pressure (54), and promoting tissue oxygen delivery with higher 
hematocrit levels (55)]. These non-invasive, non-pharmacologic 
strategies may lead to a resolution of the low diastolic pressure, 
improve CO and SBF, by limiting pulmonary overcirculation, and 
avoidance of the need for medical intervention. Such shunt limit-
ing strategies may also act as temporizing measures while defini-
tive medical treatment for PDA is underway (53, 54). Limitation 
of shunt volume during administration of medical treatment may 
enhance PDA closure, although the latter has not been formally 
studied. Despite augmentation of both non-pharmacologic 
and medical therapies, selected infants may still progress to a 
more advanced disease state with cardiovascular compromise 
characterized by both diastolic and systolic hypotension. These 
infants have persistent systemic hypoperfusion (decreased LVO) 
necessitating the addition of positive inotropes to support sys-
tolic dysfunction without causing systemic vasoconstriction. 
Dobu tamine, with its ability to raise CO by increasing SV and 
preserving SVR through offsetting β2-mediated vasodilation and 
α1-mediated vasoconstriction in the peripheral circulation, may 
be the preferred treatment option to support systolic dysfunction 
with an hsDA. In contrast, dopamine, acting as an agonist of mul-
tiple receptors, including α, β, and dopaminergic receptor, raises 
SV, PVR (56, 57), and SVR (10, 58) in the setting of the hsDA. 
Although arterial pressure may be augmented with dopamine, 
6Rios et al. Hypotension Related to the DA in Neonate
Frontiers in Pediatrics | www.frontiersin.org March 2018 | Volume 6 | Article 62
the negative impact of profound vasoconstriction on end-organ 
perfusion is a concern as it may actually be hidden from clinical 
detection (59). Other potent systemic vasoconstrictors, such 
as vasopressin and norepinephrine, should also be avoided for 
their similar effects on systemic vascular tone. A comparative 
evaluation of these agents in the setting of hsDA has not been 
performed (10).
HeMODYNAMiC iNSTABiLiTY 
FOLLOwiNg PDA TReATMeNT
Characteristic hemodynamic changes of circulatory insufficiency 
and systemic hypotension can often be seen in the period follow-
ing closure of the PDA. Awareness of the potential hemodynamic 
consequences of ductal treatment and understanding the patho-
physiologic basis of these alterations are key to effective manage-
ment of neonates in the posttreatment period. Indomethacin, 
often used to augment pharmacological PDA closure, can lead 
to significant reduction of cerebral, mesenteric, renal, and even 
coronary blood flow velocities due to its potent vasoconstrictor 
properties (38, 60–62). Though such effects are temporary and 
revert back to normal once the treatment is completed, they 
still have the potential to lead to serious consequences related to 
target organ flow, e.g., necrotizing enterocolitis, renal dysfunc-
tion, etc. Agents such as ibuprofen and acetaminophen have not 
demonstrated such deleterious effects on organ perfusion and are 
increasingly being preferred by clinicians over indomethacin for 
treatment of an hsDA (1, 63). There remains a gap of knowledge 
on ibuprofen prophylaxis and treatment side-effect profiles in 
preterm infants, highlighting the need for further randomized 
prospective studies to isolate the impact of PDA and its treatment 
options on the risks in this population (64).
Cardiovascular instability in the postoperative period is a seri-
ous concern after PDA ligation surgery (65, 66). This entity has 
been described as the post-ligation cardiac syndrome (PLCS) and 
occurs secondary to sudden, drastic changes of the loading condi-
tion on the left side of the heart following ligation. The clinical 
phenotype of PLCS is often presented by 6–12 h post-ligation and 
characterized by systolic hypotension (less than third percentile) 
and normal or elevated diastolic BP that often requires inotropic 
support (66–69). Concomitant to the systemic circulatory 
insufficiency, PLCS (left untreated) can present with difficulty 
in ventilation and increasing oxygen demands from left heart 
failure and the resultant pulmonary congestion and pulmonary 
venous hypertension. Risk factors associated with PLCS include 
earlier age at ligation (69), lower birth weight (70), younger 
gestational age (70–72), large PDA (65), and level of preoperative 
cardiorespiratory support (66, 68, 72). Recent studies have dem-
onstrated little to no clinical PLCS with catheter-based closure 
interventions, but the infants were older and weighed more at 
the time of closure compared to studies where infants underwent 
surgical ligation (73). Although there was still echocardiographic 
evidence for diminished left ventricular systolic function with 
the catheter-based approach (73), larger scale prospective studies 
are needed to determine the true incidence of PLCS with this 
procedure.
The mechanisms of PLCS are complex and incorporate 
both myocardial dysfunction and vascular tone dysregulation 
(Figure  3) (74). Ligation of the DA results in an immediate 
reduction of left atrial filling pressure (decrease in the preload on 
the left heart) as the excess volume that was being derived from 
the large left-to-right shunt is now eliminated. Cardiovascular 
compromise may initially result from the “low-preload associ-
ated reduction in contractility,” according to the Frank–Starling 
relationship (10, 65). Owing to the observation that the effect 
of preload change is greatest within the first 1–2 h after surgery 
and LV systolic dysfunction occurs around 8  h after surgical 
intervention, coinciding with clinical deterioration (2, 66), the 
major contributor to the hemodynamic instability in PLCS 
is the sudden LV exposure to the increased SVR (elevated 
afterload). In healthy term infants and preterm infants without 
an hsDA, gradual physiologic closure of the left-to-right shunt 
represents a return to a euvolemic state (55). Sudden removal 
of the left-to-right shunt following ligation, however, reflects a 
maladaptive low-flow state where the premature myocardium is 
unable to tolerate the increased afterload, leading to an increase 
in LV systolic wall stress, progressive LV systolic dysfunction 
[decreased LV shortening fraction and velocity of circumferential 
fiber shortening, VCFc (66)] with reduced contractility [altered 
stress(force)–velocity relationship (55, 66)], decline in LVO, and 
fall in SAP (initially with preserved or elevated diastolic BP) over 
a period of 6–12 h after surgery (66). The preterm myocardium 
is stiff and relaxes poorly; progression to diastolic dysfunction 
will eventually be seen in more advanced disease. Prior to proper 
recognition of PLCS, up to 45% of premature neonates were 
reported to suffer from this complication (2, 74).
Non-cardiovascular contributors to the PLCS pathophysiol-
ogy, such as adrenal insufficiency, have also been investigated 
(67, 78, 79). Most preterm neonates undergoing PDA ligation 
can mount a sufficient cortisol response perioperatively and low 
cortisol levels do not correlate to lower CO postoperatively (67). 
A relatively low preoperative cortisol response (defined as post-
ACTH cortisol ≤750 nmol/L) was significantly associated with 
postoperative hypotension (67). The nature of the hypotension in 
the setting of impaired adrenal responsiveness is characterized by 
an early (less than 4 h) fall in both systolic and diastolic arterial 
pressure. Low cortisol levels at 12 h postsurgery are associated 
with hypotension refractory to inotropes (79). Taken together, 
adrenal insufficiency may be an important factor in the subset 
of neonates with PLCS who fail to respond to catecholamines. 
ACTH stimulation to assess the stress response may be considered 
in these situations (67). Acute hypotension in the postoperative 
period can sometimes also arise due to surgical complications 
such as bleeding, tension pneumothorax, or pulmonary arterial 
(PA) hypertension that should also be considered in the differen-
tial diagnosis.
A holistic appraisal with careful monitoring and appropriate 
interpretation of all the clinical and laboratory measures of car-
diovascular wellbeing, in addition to the use of targeted neonatal 
echocardiography (TNE), is crucial in the immediate postopera-
tive period. Clinical and biochemical signs of CO and end organ 
perfusion, such as tachycardia, capillary refill time, urine output, 
lactate, base excess, etc., are non-specific, but may provide clues 
FigURe 3 | Hemodynamic alterations and clinical algorithm following patent DA (PDA) ligation. L to R, left to right; GA, gestational age; SAP, systolic arterial 
pressure; DAP, diastolic arterial pressure; PLCS, post-ligation cardiac syndrome. *Transient hypertension, with a predominant increase in diastolic blood pressure, 
has also been observed in the immediate postoperative period following PDA ligation (75), lasting for a variable amount of time, but rarely beyond the first 24–48 h 
post-ligation. Persistent hypertension lasting days or weeks and hypertension needing treatment are relatively rare complications, with only a few cases reported in 
infants and older children (76, 77). Post-PDA treatment hypertension is ascribed to the increased systemic vascular resistance (SVR), resulting from sudden 
obliteration of the low-resistance ductal pathway, along with some degree of vasomotor dysregulation in the presence of maintained myocardial performance. 
**Consider hydrocortisone (refractory hypotension with adrenal insufficiency) with systolic and/or diastolic hypotension.
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as to the state of the underlying circulation (5). Blood pressure 
monitoring, preferably by an invasive method, is crucial. Relying 
solely on MAP will be misleading as the increase in the DAP 
may mask the decline in MAP, as PLCS often presents with an 
isolated decline in SAP (1). Diastolic hypotension is unusual and 
should prompt searching for other causes such as hemorrhage, 
tension pneumothorax, sepsis, or adrenal insufficiency (2). Chest 
radiographs can rule out any postsurgical complications such 
as pneumothorax or effusion and may provide insight into the 
presence of pulmonary congestion secondary to left heart failure. 
Early TNE at 1  h post-ligation can help to identify potential 
cardiovascular compromise, as critically low LVO (<200  mL/
kg/min) predicts the development of PLCS (68). Preoperative 
echocardiographic assessment of ventriculo–arterial coupling 
may also play a role in detecting PLCS, as infants with higher 
contractility (LV end-systolic elastance) in the setting of lower 
afterload (arterial elastance) perioperatively will not respond as 
favorably to acute changes in loading conditions that are evident 
with PDA ligation (74, 80).
The management strategy in the post PDA ligation period 
strives for prevention of PLCS with early modulation of the 
postoperative physiology of elevated afterload, reduced preload, 
and systolic and diastolic dysfunction (2). Baseline preoperative 
risk factors should be analyzed in conjunction with early echo-
cardiographic data such as low LVO (<200  mL/kg/min) (68). 
If such an assessment suggests high risk of PLCS, then targeted 
prophylaxis with milrinone, a phosphodiesterase III inhibitor 
with inodilator properties, is being implemented as standard 
prophylactic care in the early phase when neonates are clinically 
stable (1). Intravenous milrinone infusion at 0.33  μg/kg/min 
concomitant with a bolus of 10–20 mL/kg of normal saline has 
been shown to significantly reduce incidence of postoperative 
cardiovascular instability (68). The fluid bolus augments preload 
and offsets the decrease in SVR associated with milrinone initia-
tion. In institutions without access to timely postoperative echo-
cardiography, the use of prophylactic milrinone in infants based 
on risk factors may be considered, but has not been properly 
studied (68).
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A different management strategy should be considered when 
a neonate presents with hypotension, and echocardiographic evi-
dence of myocardial dysfunction ± low CO in the post-ligation 
period. The optimal approach is to augment contractility without 
increasing afterload. Intravenous dobutamine represents a rational 
choice for patients with isolated SAP whereas epinephrine may be 
preferable for patients with low MAP. Agents that increase after-
load such as dopamine, vasopressin, and norepinephrine should 
be avoided. Milrinone therapy, although biologically plausible 
as a preventative agent, is undesirable in an already hypotensive 
neonate. The role of hydrocortisone in the postoperative period 
is controversial. There is no evidence to support preoperative use 
of stress dose hydrocortisone (81). Neonates presenting with pre-
dominantly diastolic hypotension and those who have had a low 
or relatively low preoperative ACTH stimulation–test response 
may benefit from hydrocortisone.
DA: SUPPORTiNg CiRCULATiON DURiNg 
MALADAPTeD TRANSiTiON
There are certain states of circulatory insufficiency when the 
patency of the DA is desirable. The supportive role of the DA 
during the transitional circulation in a structurally normal heart 
may be best demonstrated in the setting of acute PH. Acute PH is 
a known cause of early cardiovascular instability and hypotension 
in neonates; it is characterized by a delayed fall in normal post-
natal PVR, may lead to impaired RV performance, and is often 
associated with persistent right-to-left shunting through the DA 
or patent foramen ovale. The clinical consequence includes severe 
arterial hypoxemia and low CO. The elevated PVR diminishes 
PBF and pulmonary venous return leading to poor left heart filling 
(preload) and low CO, despite initial normal LV and RV systolic 
performance (82). The right-to-left shunt is an important aid to 
the postductal circulation, particularly in the setting of severe 
RV dysfunction where CO may be compromised. The initial pre-
served diastolic pressures with resultant systolic hypotension and 
right-to-left shunting of blood flow through the DA will produce 
differential cyanosis, detected by pre- and postductal PaO2 and 
oxygen saturation gradients. Survival in acute PH depends on 
proper hemodynamic coupling of the RV with the compliant PA 
circulation. With the failure of PVR to fall and a non-compliant 
PA circulation, the RV adapts to the increased afterload in acute 
PH by raising ventricular contractility to maintain the hemody-
namic coupling of the RV to the PA circulation. However, with the 
RV’s limited contractile reserve and a further rise in RV afterload 
contributing to increased systolic wall stress, ventricular contrac-
tility will eventually not be able to meet the demand and the RV 
will uncouple from its afterload with a decrease in RV efficiency 
(83). In this setting of acute PH, removal of the placenta leads 
to a state of failed adaptation with increased afterload that alters 
the force–velocity relationship and reduces contractility and CO 
(55). In addition, the high RV systolic pressure in acute PH may 
reduce the perfusion pressure of the right coronary artery that 
normally is perfused in both systole and diastole further impair-
ing RV function and CO (84). As a result, the metabolic shift from 
oxidative mitochondrial metabolism to aerobic glycolysis will 
further promote progressive RV dilation, dysfunction, failure, 
and possible ischemia (83).
Deterioration of RV performance may eventually affect 
LV function, in part due to shared myocardial fibers and ven-
tricular–ventricular interaction (82). With advanced PH, loss 
of vascular tone and ventricular dysfunction will result in both 
diastolic and systolic hypotension. In all these scenarios, the 
DA must serve as an alternate pathway for RV output. When 
systemic pressures are less than pulmonary pressures, blood may 
more easily travel from the right side of the heart to the systemic 
circulation via the DA (RV–DA–Aorta route), than from the 
traditional pathway through the pulmonary circulation to the 
left side of the heart. In patients with RV dysfunction where 
the DA is closed or restrictive, forward blood flow is limited by 
increased PVR and not shunted through the DA to support the 
systemic circulation, leading to a further deterioration in RV 
performance owing to increased systolic wall stress (85). In this 
case, the DA can potentially be reopened with PGE infusion 
to allow it to serve its role in support of the RV and systemic 
perfusion (82). Therapeutic goals in neonates with oxygenation 
failure and compromised systemic hemodynamics, therefore, 
include reduction of PVR, improvement of ventricular–vascular 
compliance, and augmentation of RV (and LV) systolic function. 
As the DA plays an important supportive role in modulating the 
neonatal circulation in this maladaptive state, echocardiography 
provides the necessary hemodynamic information that confirms 
clinical suspicion and facilitates monitoring of the response to 
therapy in these critically ill neonates. Finally, when systemic 
pressures surpass pulmonary pressures with medical and/or 
therapeutic augmentation, the shunt direction through the DA 
will change from predominantly right-to-left to a left-to-right 
flow pattern. At that time, prostaglandin infusion can be stopped 
as the DA is no longer needed in its supportive capacity and it 
may be allowed to close.
ROLe OF DA iN NeONATeS wiTH 
CRiTiCAL CONgeNiTAL CARDiAC 
DeFeCTS
There are certain critical congenital cardiac lesions that can lead 
to acute cardiovascular collapse and rely on the supportive role of 
the DA to provide systemic and/or PBF (Table 1). Neonates with 
congenital heart defects (CHD) and ductal dependency can be 
categorized into three broad groups: (1) right-sided obstructive 
lesions with DA dependent pulmonary circulation in the setting 
of severe restriction of PBF, (2) left-sided obstructive lesions with 
DA-dependent systemic circulation; and (3) adequate mixing of 
the pulmonary and systolic blood flow that is DA dependent to 
maintain the circulation in series.
For those infants diagnosed in the antenatal period with ductal-
dependent CHD, PGE is initiated shortly after delivery (86). In 
neonates diagnosed postnatally with ductal-dependent CHD, PGE 
must be initiated as soon as possible, sometimes at a higher dose 
to facilitate reopening of the DA. The specific role of the DA is 
dependent on the type of CHD diagnosed in each patient. In con-
genital heart lesions that involve an anatomic obstruction to PBF 
TABLe 1 | DA in specific critical congenital cardiac defects.
Role of DA examples Clinical findings
DA required 
for adequate 
pulmonary blood 
flow (PBF)
•	 Tetralogy of Fallot 
depending on degree of 
pulmonary stenosis
•	 Double-outlet right ventricle 
with subaortic ventricular 
septal defect (VSD) and 
pulmonary stenosis
•	 Tricuspid atresia
•	 Pulmonary atresia
•	 Critical pulmonary stenosis
•	 Severe Ebstein’s anomaly
•	 Single ventricle with 
pulmonary stenosis
Infant presents with cyanosis 
and hypoxia
Inadequate PBF initially 
manifests with systolic 
hypotension due to 
compromised left ventricle 
preload followed by diastolic 
(combined) hypotension
DA required 
for adequate 
systemic blood 
flow (SBF)
•	 Aortic stenosis
•	 Coarctation of the aorta
•	 Aortic arch interruption
•	 Hypoplastic left heart 
syndrome
•	 Multiple left heart defects
Infant presents with signs 
of poor perfusion with weak 
or absent pulses in lower 
extremities
Inadequate SBF manifests 
with profound systolic 
hypotension and may 
progress to shock
DA required 
for right to left 
shunt to ensure 
adequate atrial 
level mixing 
in parallel 
circulations with 
poor mixing
•	 d-transposition of great 
arteries
•	 d-transposition of great 
arteries and VSD
•	 Double-outlet right ventricle 
with sub-pulmonary VSD
Infant may present with early 
profound hypoxia in presence 
of restrictive PFO
Parallel circulations without 
mixing ultimately results in 
profound, lethal systemic 
hypoxia
DA may 
contribute to 
increased PBF 
and cyanosis 
in lesions with 
complete mixing
•	 Total anomalous pulmonary 
venous connection
•	 Truncus arteriosus
•	 Single ventricle without 
pulmonary stenosis
•	 Double-outlet right ventricle 
with sub-aortic VSD 
and without significant 
pulmonic stenosis
Infant usually presents with 
mild hypoxia
Infants with obstructed 
pulmonary venous connection 
will present with profound 
systemic hypoxia and systolic 
hypotension
DA, ductus arteriosus.
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infants present as cyanotic and hypoxic with usual oxygen satura-
tions between 75 and 85%. In the absence of a patent DA, infants 
will become profoundly hypoxic with little to no source of PBF as 
the DA constricts and closes. This may further manifest as early 
systolic hypotension due to the severely compromised LV preload, 
followed by diastolic hypotension, as the hypoxemia compromises 
vascular tone. Further complications may include arrhythmias, 
respiratory failure, and heart failure. The DA is required until surgi-
cal intervention or palliation to provide an alternate source of PBF.
In congenital heart lesions that involve an anatomic obstruc-
tion to SBF, the DA is required to maintain adequate systemic 
perfusion (87). These lesions are termed ductal-dependent for 
SBF and present with signs of poor perfusion in the presence of 
a constricting or closed DA with profound systolic hypotension. 
Additional signs and symptoms include weak or absent pulses, 
metabolic acidosis, lactic acidosis, and shock. The purpose of the 
DA in these cases is to facilitate right-to-left shunting of blood, 
albeit with a lower oxygen concentration, which bypasses the 
varying degrees of obstructive left-sided lesion. PGE is required 
to maintain patency of the DA with permissive hypoxemia until 
surgical repair is performed.
The DA has a specific role in lesions with parallel circulations 
and poor mixing (87). With the circulations in parallel, atrial level 
communication is critical for mixing. The DA provides right-to-
left shunting in order to increase left atrial pressures and improve 
atrial level mixing. The DA must remain patent until adequate 
atrial mixing is established and confirmed; this may require atrial 
septostomy in the newborn period. If adequate atrial mixing is 
maintained, the DA may be allowed to close prior to surgical 
correction of the underlying pathology.
The role of the DA is more complicated in other mixing lesions, 
though the clinical presentation may still be cyanosis. In lesions 
with complete mixing in the presence of a left-to-right shunt 
at the DA, the source of cyanosis is often from increased PBF, 
which can lead to tachypnea and respiratory distress (88). In these 
cases, supplemental oxygen and other interventions that decrease 
PVR can contribute to a further increase in PBF at the expense 
of the systemic circulation, ultimately resulting in hypotension 
and shock. PGE is often avoided to minimize worsening systemic 
perfusion that would be associated with a significant left to right 
shunt at the DA. In cases where ductal-dependent congenital 
lesions accompany a mixing lesion, such as coarctation of the 
aorta or interrupted aortic arch, PGE will be required to maintain 
DA patency in support of the accompanying lesions.
CONCLUSiON
The DA is essential in fetal life, important in early transition, 
potentially detrimental in select preterm populations, and sup-
portive in specific disease processes in the structurally normal and 
abnormal heart. Cardiovascular compromise and hypotension 
may occur at each postnatal stage and the DA plays a dynamic 
role in modulating the neonatal circulation. Therefore, under-
standing the pathophysiologic basis of such instability arising due 
to the DA and early recognition of the typical clinical phenotype 
characterizing the various disease stages is essential for proper 
diagnosis, monitoring, and therapeutic support. In certain cases, 
the treatment for an hsDA can lead to serious cardiovascular 
compromise in premature neonates. Analyzing systolic and dias-
tolic hypotension separately, instead of focusing solely on MAP, 
may provide early insight into the mechanistic contribution of 
the DA, which can then be evaluated in conjunction with using 
TNE. A holistic diagnostic approach that synthesizes clinical 
signs, biochemical values, and echocardiographic evidence can 
be utilized to devise focused, individualized, physiology-based 
treatment strategies that optimize management of these challeng-
ing patients and has the potential to improve patient outcomes.
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